Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy
Hualong Mo, Jie-Ying Liu, Zhengxi Su, Deng‐Gao Zhao, Yanyan Ma, Kun Zhang, Qi Wang, Chun Fu, Yao Wang, Meiwan Chen, Burong Hu
Topics & Concepts
Hydroxamic acidChemistryIn vivoNatural productSTAT3Histone deacetylasePharmacologyAutophagySTAT proteinBioavailabilityApoptosisBiochemistryCancer researchHistoneBiologyStereochemistryBiotechnologyDNAHistone Deacetylase Inhibitors ResearchPeptidase Inhibition and AnalysisCatalytic C–H Functionalization Methods